Variant report
Variant | nsv613303 |
---|---|
Chromosome Location | chr9:9187539-9225463 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10977555 | chr9:9187539-9187540 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs116312351 | chr9:9187556-9187557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543488958 | chr9:9187575-9187576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs375062105 | chr9:9187604-9187605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73403472 | chr9:9187605-9187606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528843323 | chr9:9187629-9187630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541135886 | chr9:9187633-9187634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559155762 | chr9:9187677-9187678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs527909030 | chr9:9187699-9187700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12686720 | chr9:9187726-9187727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184229857 | chr9:9187767-9187768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187560116 | chr9:9187780-9187781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs5896309 | chr9:9187781-9187782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79380914 | chr9:9187790-9187791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192781661 | chr9:9187799-9187800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561553503 | chr9:9192025-9192026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs530386206 | chr9:9192041-9192042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368453298 | chr9:9192076-9192077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538167940 | chr9:9192115-9192116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563109539 | chr9:9192161-9192162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142034632 | chr9:9192200-9192201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527876090 | chr9:9192212-9192213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs575227005 | chr9:9192222-9192223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548398826 | chr9:9192223-9192224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374343144 | chr9:9192225-9192226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372013080 | chr9:9192233-9192234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570907507 | chr9:9192234-9192235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537998412 | chr9:9192252-9192253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139920046 | chr9:9192257-9192258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568376530 | chr9:9192264-9192265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187044379 | chr9:9192266-9192267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2166235 | chr9:9192273-9192274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554109292 | chr9:9192275-9192276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201057345 | chr9:9192289-9192290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574727062 | chr9:9192299-9192300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539630066 | chr9:9192328-9192329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149262648 | chr9:9192365-9192366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540485952 | chr9:9192370-9192371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560708431 | chr9:9192372-9192373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543169945 | chr9:9192389-9192390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs79466211 | chr9:9192468-9192469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573559648 | chr9:9192473-9192474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548911746 | chr9:9192493-9192494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147384569 | chr9:9192506-9192507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560404352 | chr9:9192539-9192540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368634393 | chr9:9192572-9192573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577469373 | chr9:9192573-9192574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs190929566 | chr9:9192578-9192579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564544556 | chr9:9192623-9192624 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531794249 | chr9:9192652-9192653 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:9187400-9187800 | Enhancers | Fetal Brain Female | brain |
2 | chr9:9192000-9192600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr9:9192600-9193200 | Active TSS | Pancreatic Islets | Pancreatic Islet |
4 | chr9:9199400-9199600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr9:9199800-9202200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr9:9200000-9200600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr9:9200000-9200800 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr9:9200000-9200800 | Enhancers | Brain Substantia Nigra | brain |
9 | chr9:9200400-9200800 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr9:9200400-9201000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr9:9200800-9202200 | Enhancers | Fetal Kidney | kidney |
12 | chr9:9201000-9201400 | Enhancers | Fetal Lung | lung |
13 | chr9:9214000-9215000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr9:9214000-9215200 | Enhancers | Fetal Kidney | kidney |
15 | chr9:9214000-9215200 | Enhancers | Fetal Lung | lung |
16 | chr9:9214000-9215400 | Enhancers | Stomach Mucosa | stomach |
17 | chr9:9215200-9218800 | Weak transcription | Fetal Lung | lung |
18 | chr9:9216800-9217400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr9:9217000-9217400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr9:9218800-9219000 | Enhancers | Fetal Lung | lung |
21 | chr9:9219000-9219400 | Weak transcription | Fetal Lung | lung |
22 | chr9:9219400-9219800 | Enhancers | Fetal Lung | lung |
23 | chr9:9225400-9225600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |